Fibre Content and Cellularity of the Bone Marrow of the Iliac Crest, Vertebral Column and Sternum in Chronic Myeloproliferative Disorders

References

• Burkhardt R., Bartl R., Jäger K., Frisch B., Mahl G., Kettner G., Sund M. Chronic myeloproliferative disorders (CMPD). Path. Res. Pract. 1984; 1: 131–186
   Google Scholar
• Georgii A., Buhr T., Büsche G., Kreft A., Choritz H. Classification and staging of Ph'- negative myeloproliferative disorders by histopathology of bone marrow biopsies. Leuk. Lymphoma 1996; 22: 15–29
   PubMed Web of Science ®Google Scholar
• Kvasnicka H. M., Thiele J., Werden C., Diehl R., Zankovich V., Fischer R. Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 1997; 80: 708–719
   PubMed Web of Science ®Google Scholar
• Rozman C., Giralt M., Feliu E., Rubio D., Cortés M. -T. Life expectancy of patients with chronic non-leukemic myeloproliferative disorders. Cancer 1991; 67: 2658–2665
   PubMed Web of Science ®Google Scholar
• Ellis J. T., Peterson P., Geller S. A., Rappaport H. Studies of the bone marrow in polycythemia Vera and evolution of myelofibrosis and second hematologic malignancies. Sem. Hematol. 1986; 23: 144–155
   PubMed Web of Science ®Google Scholar
• Wolf B. C., Neiman R. S. Myelofibrosis and mye-loid metaplasia: Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 1985; 65: 803–809
   PubMed Web of Science ®Google Scholar
• Thiele J., Rompcik V., Wagner S., Fischer R. Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia Vera: An immunomorphometric study on trephine biopsies of the bone marrow. Br. J. Haematol. 1992; 80: 227–234
   PubMed Web of Science ®Google Scholar
• Kaplan Mitchell K.R., Steiner D. G., Murphy R. M., Vinitski S., Rao S., Burk V. M.D. L., Rifkin M. D. Polycythemia Vera and myelofibrosis: Correlation of MR imaging, clinical, and laboratory findings. Radiol. 1992; 183: 329–334
   PubMed Web of Science ®Google Scholar
• Gückel F., Brix G., Semmler W., Zuna I., Ho W., Knauf A. D., van Kaick G. Systemic bone marrow disorders: Characterization with proton chemical shift imaging. J. Comput. Assist. Tomogr. 1990; 14: 633–642
   PubMed Web of Science ®Google Scholar
• Guermazi A., de Kerviler E., Cazals-Hatem D., Zagdanski A. -M., Frija J. Imaging findings in patients with myelofibrosis. Eur. Radiol. 1999; 9: 1366–1375
   PubMed Web of Science ®Google Scholar
• Jamshidi K., Swaim W. R. Bone marrow biopsy with unaltered architecture. A new biopsy device. J. Lab. Clin. Med. 1971; 77: 335–342
   PubMed Web of Science ®Google Scholar
• Burkhardt R. Praparative Voraussetzungen zur kli-nischen Histologie des menschlichen Knochenmarks. Blut 1966; 13: 337–357
   PubMedGoogle Scholar
• Bernhards J., Weitzel B., Werner M., Rimpler M., Georgii A. A new histological embedding method by low-temperature polymerisation of methyl methacrylate allowing immuno- and enzyme histological studies on semi-thin sections of undecalcified bone marrow biopsies. Histochem. 1992; 98: 145–154
   Google Scholar
• Weibel E. R. Stereological methods Vol. 1: Practical methods for biological morphometry. Academic Press, London 1979
   Google Scholar
• Kreft A., Nolde C., Busche G., Buhr T., Georgii A. Polycythaemia Vera: Bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan. Eur, J. Haematol.
   PubMed Web of Science ®Google Scholar
• Godfrey K. Comparing the means of several groups. Medical use of statistics2nd., J. C. Bailar, F. Mosteller. NHM Books, Boston 1992; 233–257
   Google Scholar
• Barcos M., Lane W., Gomez G. A., Han T., Freeman A., Pre-isler H., Henderson E. An autopsy study of 1205 acute and chronic leukemias (1958 to 1982). Cancer 1987; 60: 827–837
   PubMed Web of Science ®Google Scholar
• Viadana E., Bross I. D.J., Pickren J. W. An autopsy study of metastatic patterns of human leukemias. Oncology 1978; 35: 87–96
   PubMed Web of Science ®Google Scholar
• Vardiman J. W., Golomb H. M. Autopsy findings in hairy cell leukemia. Sem. Oncol. 1984; 11: 370–380
   PubMed Web of Science ®Google Scholar
• Hasle H., Mellemgaard A. Hodgkin' disease diagnosed post mortem: A population based study. Br. J. Cancer 1993; 67: 185–189
   PubMed Web of Science ®Google Scholar
• Gerain J., Sculier J. P., Malengreaux A., Rykaert C., Thémelin L. Causes of deaths in an oncologic intensive care unit: A clinical and pathological study of 34 autopsies. Eur: J. Cancer 1990; 26: 317–381
   Google Scholar
• Garvin A. J., Simon R. M., Osborne K., Merrill J., Young R. C., Bernhard C. W. An autopsy study of histologic progression in non-Hodgkin's lymphomas: 192 cases from the national cancer institut. Cancer 1983; 52: 393–398
   PubMed Web of Science ®Google Scholar
• Kapadia S. B. Multiple myeloma: A clinicopathologic study of 62 consecutively autopsied cases. Medicine 1980; 59: 380–392
   PubMed Web of Science ®Google Scholar
• Thiele J., Laubert A., Vykoupil K. F., Georgii A. Autopsy and clinical findings in acute leukemia and chronic myeloproliferative diseases. Path. Res. Pract. 1985; 178: 328–336
   Google Scholar
• Burkhardt R., Bartl R., Jäger K., Ehret W., Schlag R., Demmler K. Histobioptische Knochenmarks-beurteilung im Senium. Hämarologie im Alter, J. Böhnel, R. Heinz, A. Stacher. Urban., & Schwarzen-berg, Wien 1982; 20–28
   Google Scholar
• Brunning R. D., McKenna R. W. Tumors of the bone marrow3rd edn. Armed Forces Institute of Pathology, Washington, D. C. 1994
   Google Scholar
• Schmitz B., Thiele J., Otto F., Farahmand P., Henze F., Frim-pong S., Wickenhauser C., Fischer R. Evidence for integrin receptor involvement in megakaryocyte - fibroblast interaction: A possible pathomechanism for the evolution of myelofibrosis. J. Cell. Physiol. 1998; 176: 445–455
   PubMed Web of Science ®Google Scholar
• Dalley A., Smith J. M., Reilly J. T., MacNeil S. Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: Evidence for a role of extracellular calmodulin in fibroblast proliferation. Br. J. Haematol. 1996; 93: 856–862
   PubMed Web of Science ®Google Scholar
• Penchansky L., Taylor S. R., Krause J. R. Three infants with acute megakaryoblastic leukemia simulating metastatic tumor. Cancer 1989; 64: 1366–1371
   PubMed Web of Science ®Google Scholar
• Bauermeister D. E. Quantification of bone marrow reticulin - a normal range. Am. J. Clin. Pathol. 1971; 56: 24–31
   PubMed Web of Science ®Google Scholar
• Bentley S. A., Herman C. J. Bone marrow fiber production in myelofibrosis: A quantitative study. Br. J. Haematol. 1979; 42: 51–59
   PubMed Web of Science ®Google Scholar
• Thiele J., Kvasnicka H. M., Niederle N., Zirbes T. K., Schmidt M., Dammasch J., Meuter B. R., Leder L., Kloke D., Diehl O. V., Fischer R. The impact of interferon versus busulphan therapy on reticulin stain-measured fibrosis in CML - a comparative morphometric study on sequential trephine biopsies. Ann. Hematol. 1995; 70: 121–128
   PubMed Web of Science ®Google Scholar
• Löfvenberg E., Wahlin A., Roos G., Ost A. Reversal of myelofibrosis by hydroxyurea. Eur J. Haemarol. 1990; 44: 33–38
   PubMed Web of Science ®Google Scholar
• Wilhelm M., Bueso-Ramos C., Obrien S., Pierce S., Keating M., Talpaz M., Kantarjian H. M. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia. Leukemia 1998; 12: 65–70
   PubMed Web of Science ®Google Scholar
• Manoharan A., Pitney W. R. Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scand. J. Haernatol. 1984; 33: 453–459
   PubMedGoogle Scholar
• McGlave P. B., Brunning R. D., Hurd D. D., Kim T. H. Reversal of severe bone marrow fibrosis and osteosclerosis following allogenic bone marrow transplantation for chronic granulocytic leukaemia. Br. J. Haematol. 1982; 52: 189–194
   PubMed Web of Science ®Google Scholar